Also trades as: RGT.L (LSE) · $vol 0M
RGT.AX ASX
Argent BioPharma Limited
1W: -6.2%
1M: +0.0%
3M: -58.3%
YTD: -46.4%
1Y: -78.6%
A$0.03 ($0.02)
-0.00 (-6.67%)
Weekly Expected Move ±8.3%
A$0
A$0
A$0
A$0
A$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$583K
-34.5% ▼
Gross Profit
$446K
+119.1% ▲
Operating Income
-$15M
+15.4% ▲
Net Income
-$18M
-1.8% ▼
EPS (Diluted)
$0.00
+100.0% ▲
EBITDA
-$17M
-7.8% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2024 |
|---|---|
| Revenue | $583K |
| YoY Growth | -34.5% |
| Cost of Revenue | $137K |
| Gross Profit | $446K |
| Gross Margin | 76.5% |
| R&D Expenses | $4M |
| SG&A Expenses | $8M |
| Operating Expenses | $16M |
| Operating Income | -$15M |
| Operating Margin | -2646.8% |
| Interest Expense | $51K |
| Income Before Tax | -$18M |
| Tax Expense | $0 |
| Net Income | -$18M |
| Net Margin | -3058.4% |
| EPS (Diluted) | $0.00 |
| EBITDA | -$17M |
| Shares Outstanding | 0 |